CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Biologics (BLA & Biosimilars)
Original article

HEPLISAV-B

HEPLISAV-BNeutral
AI Analysis

Summary

HEPLISAV-B is indicated for prevention of hepatitis B virus infection in adults 18 years and older across all known subtypes.

Importance:1/10
Sentiment:
0.00
hepatitis Bvaccineindication
Related Companies

Read the original article

Published by FDA Biologics (BLA & Biosimilars) on July 8, 2026 3:39 PM

Read Original